Organization
Cancer Center, West China Hospital, Sichuan University
1 abstract
Abstract
An open-label, multicenter, phase I study of ATG-022 in patients with advanced/metastatic solid tumors (CLINCH).Org: Cancer Center, West China Hospital, Sichuan University, Cabrini Health Limited, Antengene Therapeutics Ltd.,